Default company panoramic image
Logo

Biomeme, Inc.

Mobile, low-cost, rapid, connected, and highly accurate molecular diagnostic that is simple and requires no special equipment to use.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Philadelphia, PA, USA
  • Currency USD
  • Founded November 2012
  • Employees 4
  • Website bio-meme.com

Company Summary

Biomeme develops innovative mobile systems for advanced DNA diagnostics. The first product transforms a smartphone into a DNA lab for point-of-need (PON) clinicians and epidemiologists identifying, tracking and developing strategies to combat pathogens and diseases. It includes low-cost mobile hardware, software, and biology and encourages the development of a wide variety of test kits from target industries as well as in-house biologists.

Team

  • Default avatar
    Marc DeJohn
    Co-Founder, Engineering Lead

    Authored 10 patents, 15-years R&D experience with emphasis on small, portable instrumentation. 6 successful startups, including the first acoustic cytometer (sold to Invitrogen) and a disposable molecular diagnostic for point-of-care. Designed and developed products spanning fields of electrochemistry, catalysis, smart materials, acoustics, robotics, micro-fluidics, and diagnostics. MS in Electroanalytical Chemistry and BS in Biology + Chemistry.

  • Default avatar
    Jesse vanWestrienen
    Co-Founder, Biology Lead

    Experienced research technologist and molecular biologist, with expertise in PCR assay development, prototyping of nucleic acid isolation devices, qRT-PCR assay development, and lyophilization development. Started Nucleic Acid Isolation and Quantitative Real-Time PCR Core Laboratory at Lovelace Respiratory Research Institute Experience in developing country settings, particularly Central America. BS in Biology.

  • Default avatar
    Einar Vollset, BSc, MSc, and PhD
    Advisor

    Founded 3 successful start-ups, including ReMail next generation mobile email sold to Google. CEO of Left Coast R&D, boutique mobile strategy and development firm specializing in rapid prototyping of iOS and Android apps. 2 years as visiting professor at Cornell University, focused on mobile distributed file systems and reliability in high performance/high latency networks. BSc, MSc, and PhD in Computer Science.

  • Default avatar
    Max Perelman
    Co-Founder, Business Lead

    15 years business experience, including 10 years international business strategy consulting, as well as eCommerce and enterprise management systems development and project management. BA from Cornell University and an MBA and MAIEP from the Monterey Institute of International Studies.

  • Default avatar
    Chris Cashman
    Advisor

    Chairman and CEO of Marinus Pharmaceuticals, Inc and Executive Chairman of Rapid Micro Biosystems. Prior to Marinus Chris co-founded Protez Pharmaceuticals and served as Director, President and CEO. Protez was acquired by Novartis in 2008. Chris also serves on the board of directors of Noble Biomaterials, MBF Therapeutics, Mid-Atlantic Diamond Ventures and the Science Center.

  • Default avatar
    Maximilian Maksutovic
    Software Engineer

    Co-founder of Lyfix Labs focused on developing personal healthcare management solutions. Experienced in iOS, Ruby on Rails, HTML5, C++, and Parse.

  • Default avatar
    Brenda Gavin
    Advisor

    Founding Partner of Quaker Partners venture capital firm. Previously: President of S.R. One, GlaxoSmithKline’s venture capitol arm, and General Partner of EuclidSR Partners, an independent venture capitol fund focused on healthcare and information technology.

  • Default avatar
    Amanda Christini
    Advisor

    Professor of Clinical Medicine and Instructor in Internal Medicine at the University of Pennsylvania Perelman School of Medicine. Co-Principle Investigator in Phase 2 study of 1a or 1b HCV infection. Previously director of business development for Maxigen as well as Valentis, and MIT’s office of technology licensing.

Advisors

  • Default avatar
    http://www.cozen.com/people/bios/nelson-david
    Lawyer
    Unconfirmed

Previous Investors

  • Default avatar
    Dreamit Ventures, Independence Blue Cross, Penn Medicine, Venturef0rth
    Unconfirmed
    Default avatar
    Woodgen, LLC
    Unconfirmed
    Default avatar
    Jared Tarbell, Edward T. Harvey, David Bolliger, Rohit Gupta
    Unconfirmed